BRAVE Strategy - Breast Cancer Risk Assessment -achieVing Equity
Clinical trial NCT05051631 · COMPLETED
Trial details
- NCT number
- NCT05051631
- Sponsor
- Vanderbilt University Medical Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-09
- Primary completion
- 2024-08-30
- Enrollment
- 1071
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.